• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nordcan.R:癌症登记数据联合分析与质量保证的新工具。

Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data.

作者信息

Larønningen Siri, Skog Anna, Engholm Gerda, Ferlay Jacques, Johannesen Tom Børge, Kristiansen Marnar Fríðheim, Knoors Daan, Kønig Simon Mathis, Olafsdottir Elinborg J, Pejicic Sasha, Pettersson David, Skovlund Charlotte Wessel, Storm Hans H, Tian Huidong, Aagnes Bjarte, Miettinen Joonas

机构信息

Department of Registration, Cancer Registry of Norway, Oslo, Norway.

Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark.

出版信息

Front Oncol. 2023 Aug 8;13:1098342. doi: 10.3389/fonc.2023.1098342. eCollection 2023.

DOI:10.3389/fonc.2023.1098342
PMID:37614501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10442944/
Abstract

AIM OF THE ARTICLE

We present our new GDPR-compliant federated analysis programme (nordcan.R), how it is used to compute statistics for the Nordic cancer statistics web platform NORDCAN, and demonstrate that it works also with non-Nordic data.

MATERIALS AND METHODS

We chose R and Stata programming languages for writing nordcan.R. Additionally, the internationally used CRG Tools programme by International Agency for Research on Cancer (IARC/WHO) was employed. A formal assessment of (GDPR-compliant) anonymity of all nordcan.R outputs was performed. In order to demonstrate that nordcan.R also works with non-Nordic data, we used data from the Netherlands Cancer Registry.

RESULTS

nordcan.R, publicly available on Github, takes as input cancer and general population data and produces tables of statistics. Each NORDCAN participant runs nordcan.R locally and delivers its results to IARC for publication. According to our anonymity assessment the data can be shared with international organizations, including IARC. nordcan.R incidence results on Norwegian and Dutch data are highly similar to those produced by two other independent methods.

CONCLUSION

nordcan.R produces accurate cancer statistics where all personal and sensitive data are kept within each cancer registry. In the age of strict data protection policies, we have shown that international collaboration in cancer registry research and statistics reporting is achievable with the federated analysis approach. Undertakings similar to NORDCAN should consider using nordcan.R.

摘要

文章目的

我们展示了我们新的符合通用数据保护条例(GDPR)的联合分析程序(nordcan.R),它如何用于为北欧癌症统计网络平台NORDCAN计算统计数据,并证明它也适用于非北欧数据。

材料与方法

我们选择R和Stata编程语言来编写nordcan.R。此外,还采用了国际癌症研究机构(IARC/世卫组织)国际通用的CRG Tools程序。对所有nordcan.R输出结果(符合GDPR要求)的匿名性进行了正式评估。为了证明nordcan.R也适用于非北欧数据,我们使用了荷兰癌症登记处的数据。

结果

nordcan.R在Github上公开可用,它将癌症和一般人群数据作为输入,并生成统计表格。每个NORDCAN参与者在本地运行nordcan.R,并将结果提交给IARC进行发布。根据我们的匿名性评估,这些数据可以与包括IARC在内的国际组织共享。nordcan.R对挪威和荷兰数据的发病率结果与另外两种独立方法得出的结果高度相似。

结论

nordcan.R在所有个人和敏感数据都保留在每个癌症登记处的情况下,能产生准确的癌症统计数据。在严格的数据保护政策时代,我们已经表明,通过联合分析方法,癌症登记研究和统计报告的国际合作是可以实现的。与NORDCAN类似的项目应该考虑使用nordcan.R。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5195/10442944/d04673bb40c3/fonc-13-1098342-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5195/10442944/85b99ab653ff/fonc-13-1098342-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5195/10442944/a52af5753329/fonc-13-1098342-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5195/10442944/d04673bb40c3/fonc-13-1098342-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5195/10442944/85b99ab653ff/fonc-13-1098342-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5195/10442944/a52af5753329/fonc-13-1098342-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5195/10442944/d04673bb40c3/fonc-13-1098342-g003.jpg

相似文献

1
Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data.Nordcan.R:癌症登记数据联合分析与质量保证的新工具。
Front Oncol. 2023 Aug 8;13:1098342. doi: 10.3389/fonc.2023.1098342. eCollection 2023.
2
Do investments in cancer registry databases and tools bring added value? NORDCAN as an example.癌症登记数据库和工具的投资是否带来附加价值?以 NORDCAN 为例。
Acta Oncol. 2023 Jun;62(6):535-540. doi: 10.1080/0284186X.2023.2218557. Epub 2023 Jun 5.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
NORDCAN--a Nordic tool for cancer information, planning, quality control and research.NORDCAN——一个北欧癌症信息、规划、质量控制和研究工具。
Acta Oncol. 2010 Jun;49(5):725-36. doi: 10.3109/02841861003782017.
5
Federated Machine Learning, Privacy-Enhancing Technologies, and Data Protection Laws in Medical Research: Scoping Review.联邦机器学习、隐私增强技术和医疗研究中的数据保护法规:范围综述。
J Med Internet Res. 2023 Mar 30;25:e41588. doi: 10.2196/41588.
6
Data harmonization and federated learning for multi-cohort dementia research using the OMOP common data model: A Netherlands consortium of dementia cohorts case study.利用 OMOP 通用数据模型进行多队列痴呆症研究的数据协调和联合学习:荷兰痴呆症队列联盟的案例研究。
J Biomed Inform. 2024 Jul;155:104661. doi: 10.1016/j.jbi.2024.104661. Epub 2024 May 26.
7
Cancer in the Faroe Islands from 1960-2019 - incidence, mortality, and comparisons with the other Nordic countries.1960-2019 年法罗群岛的癌症发病情况、死亡率及与其他北欧国家的比较。
Acta Oncol. 2022 Aug;61(8):907-915. doi: 10.1080/0284186X.2022.2082885. Epub 2022 Jun 3.
8
Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies.北欧国家 1990-2016 年癌症生存趋势:NORDCAN 生存研究。
Acta Oncol. 2020 Nov;59(11):1266-1274. doi: 10.1080/0284186X.2020.1822544. Epub 2020 Oct 19.
9
Survival trends in patients diagnosed with colon and rectal cancer in the nordic countries 1990-2016: The NORDCAN survival studies.北欧国家 1990-2016 年确诊结肠癌和直肠癌患者的生存趋势:NORDCAN 生存研究。
Eur J Cancer. 2022 Sep;172:76-84. doi: 10.1016/j.ejca.2022.05.032. Epub 2022 Jun 24.
10
The potential of federated learning for public health purposes: a qualitative analysis of GDPR compliance, Europe, 2021.联邦学习在公共卫生领域的潜力:对 GDPR 合规性的定性分析,欧洲,2021 年。
Euro Surveill. 2024 Sep;29(38). doi: 10.2807/1560-7917.ES.2024.29.38.2300695.

引用本文的文献

1
The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN.北欧国家阴茎癌的过去、现在和未来。北欧癌症登记协会(NORDCAN)的结果。
BJUI Compass. 2025 Jun 27;6(7):e70041. doi: 10.1002/bco2.70041. eCollection 2025 Jul.
2
Making the Case for an International Childhood Cancer Data Partnership.推动建立国际儿童癌症数据伙伴关系的理由。
J Natl Cancer Inst. 2025 Jan 12. doi: 10.1093/jnci/djaf003.
3
Advancements in skin cancer treatment: focus on photodynamic therapy: a review.皮肤癌治疗的进展:聚焦光动力疗法:一篇综述

本文引用的文献

1
Nordic Cancer Registries - an overview of their procedures and data comparability.北欧癌症登记处——程序和数据可比性概述。
Acta Oncol. 2018 Apr;57(4):440-455. doi: 10.1080/0284186X.2017.1407039. Epub 2017 Dec 11.
2
NORDCAN--a Nordic tool for cancer information, planning, quality control and research.NORDCAN——一个北欧癌症信息、规划、质量控制和研究工具。
Acta Oncol. 2010 Jun;49(5):725-36. doi: 10.3109/02841861003782017.
3
Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.癌症登记处数据质量评估:原则与方法 第二部分。完整性。
Am J Cancer Res. 2024 Oct 25;14(10):5011-5044. doi: 10.62347/JOUT3260. eCollection 2024.
4
Facing further challenges in cancer data quality and harmonisation.癌症数据质量与整合面临进一步挑战。
Front Oncol. 2024 Jul 25;14:1438805. doi: 10.3389/fonc.2024.1438805. eCollection 2024.
5
TNM stage in the Nordic Cancer Registries 2004-2016: Registration and availability.2004-2016 年北欧癌症登记处的 TNM 分期:登记和可获得性。
Acta Oncol. 2024 May 7;63:303-312. doi: 10.2340/1651-226X.2024.35232.
6
Non-preventable cases of breast, prostate, lung, and colorectal cancer in 2050 in an elimination scenario of modifiable risk factors.2050 年消除可改变风险因素情景下可避免的乳腺癌、前列腺癌、肺癌和结直肠癌病例数。
Sci Rep. 2024 Apr 13;14(1):8577. doi: 10.1038/s41598-024-59314-x.
Eur J Cancer. 2009 Mar;45(5):756-64. doi: 10.1016/j.ejca.2008.11.033. Epub 2009 Jan 6.
4
Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness.癌症登记处数据质量评估:原则与方法。第一部分:可比性、有效性和及时性。
Eur J Cancer. 2009 Mar;45(5):747-55. doi: 10.1016/j.ejca.2008.11.032. Epub 2008 Dec 29.
5
Prediction of cancer incidence in the Nordic countries up to the year 2020.对北欧国家截至2020年癌症发病率的预测。
Eur J Cancer Prev. 2002 Jun;11 Suppl 1:S1-96.
6
Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries.北欧国家截至2000年和2010年癌症发病率的预测。北欧五个癌症登记处的合作研究。
APMIS Suppl. 1993;38:1-124.
7
Epidemiology of gastrointestinal cancers in Scandinavia. I. Report on Denmark, Finland, Norway, and Sweden.斯堪的纳维亚地区胃肠道癌症的流行病学。I. 丹麦、芬兰、挪威及瑞典的报告。
Natl Cancer Inst Monogr. 1967 Jul;25:219-39.
8
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.北欧国家癌症发病率趋势。北欧五个癌症登记处的合作研究。
Acta Pathol Microbiol Immunol Scand Suppl. 1986;288:1-151.